TRENDS
Bribery case part of ‘larger conspiracy’ to prevent me from being DCGI: S Eswara Reddy
A CBI court has rejected the bail pleas of Joint Drug Controller S Eswara Reddy and four others for allegedly taking a bribe to waive the phase-3 clinical trial of the Insulin Aspart injection of Biocon Biologics
TRENDS
Government launches scheme for pharma sector to step up capacity, upgrade to global standards
The Centre aims the scheme will help the existing pharmaceutical clusters' in attaining sustained growth.
TRENDS
Opium processing lucrative business with high margins: Bajaj Healthcare MD Anil Jain
Bajaj Healthcare has been awarded two government tenders for the manufacture of concentrated poppy straw alkaloids and active pharmaceutical ingredients from unlanced poppy capsules. Opium processing in India has so far been handled only by the Government Opium & Alkaloid Factories.
TRENDS
CBI court to pronounce order in CDSCO bribery case today
The court will also give its order on an application to test voice samples of all the arrested in a bribery scandal reportedly involving a joint senior executive of Biocon Biologics.
BUSINESS
Move to open opium market to private players could take Rs 1,000 crore business to new highs
Moneycontrol takes you into India’s poppy fields to explain what opium derivatives are used for and gives you a whiff of this narcotic’s potent economic potential.
INDIA
CBI special court reserves S Eswara's bail application in bribery case
The CBI counsel today requested the special court for voice sampling of all the five accused.
TRENDS
MC Explains | What is Cervavac? India’s first cervical cancer vaccine
India shares more than a quarter of the global cervical cancer burden although the country contributes 17 percent of the world’s population.
TRENDS
Tax raids on Dolo 650 maker, officials say cash, jewellery worth Rs 2.6 crore seized
The IT sleuths conducted a search operation on 36 premises spread across 9 states. MicroLabs’s Dolo 650 made big money during COVID-19 and the company became a market leader in the sector.
TRENDS
Centre plans second-generation COVID vaccines to tackle mutating variants
But immunologists are not convinced, noting that new vaccines may not be needed as COVID has become endemic.
TRENDS
Bajaj Healthcare enters tightly regulated but lucrative opium-processing business
BHL told exchanges that it plans to execute both the tenders at its API manufacturing unit in Gujarat's Savli
TRENDS
PIVOT: The AI-based tool that can predict cancer-causing genes
Researchers at the Indian Institute of Technology (IIT), Madras, who developed the tool, says the prediction is based on a model that utilises information about mutations and expression of genes.
INDIA
Research crucial for Indian pharma industry to move from ‘volume’ to ‘value’: Mansukh Mandaviya
In order to provide impetus to the research in pharmaceutical sector, Mandaviya said that the union government has drafted a separate policy for research and development.
INDIA
NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years
Biological E’s Corbevax has been recommended for administration in 5 to 12 years old children, while the Bharat Biotech’s Covaxin has been recommended for children in 6-12 years’ age group.
INDIA
High levels of toxic chemical detected in drinking water across India
Water samples were found to contain a high concentration of nonylphenol, which can harm nervous, reproductive and immune systems, a study by Delhi-based NGO Toxics Link has said
TRENDS
Healthcare associations write to FM, raise concerns over 5% GST on hospital room rent
The Association of Working Group of Hospitals says the decision is contrary to the government's policy to provide affordable healthcare to all.
INDIA
As CGHS dues pile up, private hospitals refuse cashless treatment to govt employees
The official said because of technical issues, payments of CGHS beneficiaries on the National Health Authority's information technology platform are not getting processed, increasing the outstanding dues.
TRENDS
Discontinue GST exemption on healthcare services; allow input tax credit, FICCI tells FM Sitharaman
The incorporation of five percent GST on room rent exceeding Rs 5,000 per day will increase the expenditure of patients, says FICCI
TRENDS
Akums Drugs gets European Union GMP nod for two manufacturing plants in Haridwar
Post approval, Akums said it will get access to markets in the entire European Union as well as many other markets.
TRENDS
Taxing patients: Hospitals protest decision to raise GST on hospital room rents above 5K a day
The tax will increase the burden on patients to whom hospitals will be forced to pass on the cost, healthcare providers say.
INDIA
Zydus gets USFDA's final approval for Lacosamide injection
Lacosamide injection is used to treat partial-onset seizures.
TRENDS
mRNA booster shot in pipeline, says Gennova Biopharmaceuticals
After getting the nod from India's drug regulator, Gennova Biopharmaceuticals is now aiming for WHO approval for its mRNA vaccine
TRENDS
MC Explains | GEMCOVAC-19, India's first mRNA Covid-19 vaccine, and how it scores over Pfizer, Moderna
Apart from being indigenously developed, the vaccine is available in powdered form without the need to be stored at sub-zero temperatures, making it easy to transport to remote areas
TRENDS
Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics
Aiming to revolutionise the cancer therapy treatment in India, Immuneel Therapeutics hopes to bring down the cost of CAR-T therapy for patients.
TRENDS
From non-availability of boosters to pending visa clearances, no end to miseries for Sputnik V takers in India
While some people complained of the non-availability of Sputnik V booster doses in hospitals, when Moneycontrol reached out to Dr Reddy’s Laboratories Ltd, the manufacturers of Sputnik V vaccines in India, a company spokesperson said the booster dose is now available in partner hospitals in Hyderabad, New Delhi, Mumbai, and Pune, and is being extended to other hospitals and cities.
